by Charlie Perrecone | Sep 27, 2013
Stewart Eisenhart, of massdevice.com, explains that Brazilian medical device regulator ANVISA is planning a multitude of updates and revisions to Brazil’s existing regulatory system to be enacted by the end of 2014. These proposed changes will affect almost all...
by Charlie Perrecone | Sep 18, 2013
Ron Leuty, of bizjournals.com, details a resurgence of the biotech venture capital industry in the San Francisco area. According to the recent Money Tree report, the bay area collected the most second quarter cash in biotech and medical device areas. Overall, the...
by Charlie Perrecone | Sep 13, 2013
Dan Stanton, of BioPharma-Reporter.com, describes the move made by the European Medicines Agency (EMA) at the beginning of the Summer of 2013 to approve two more biosimilars. This approval of these biosimilars pushes the total available in Europe to fourteen. Deepa...
by Charlie Perrecone | Aug 23, 2013
Pearl Pathways’ website has recently seen a few upgrades in content. The News & Events section now provides a easy to read layout, two new pharmaceutical and one new medical device Case Studies have been added, and several of the Services pages have been...
by Charlie Perrecone | Jul 23, 2013
Pearl Pathways will be joining more than 500 clinical executives making the commitment to research site success at the 2013 Site Solutions Summit. Hosted by the Society for Clinical Research Sites, the Summit provides 3 days of networking and takeaways designed to...
